Home  >  Research  >  Labs  >  Cancer Program  >  LIVER DISEASE AND CARCINOGENESIS

RESEARCH OVERVIEW

Our research group focuses on the liver progenitor/stem cell (LPSC) which we identify in patients with alcoholic liver disease (ALD), hepatitis C (HCV), genetic hemochromatosis (GH) and non-alcoholic fatty liver disease (NAFLD). An objective of our research is to utilise their presence as a diagnostic to detect early stages of pathology and their abundance as an indicator of disease severity. Since ALD, GH, HCV and NAFLD increase the likelihood of developing hepatocellular carcinoma (HCC), the LPSCs may also be useful as a prognostic for patients who will develop liver cancer.

We are well-placed to undertake these studies as we have a monoclonal antibody that detects the LPSCs in liver biopsies. Our recent studies suggest that the protein this antibody binds to is present in the blood of patients who harbour LPSCs in their liver. This raises the possibility of developing a blood test that informs clinicians of the state of the patient’s liver.

The LPSC is present in diseased liver because it has an important role in repairing the damaged organ. It is a functional stem cell that can produce cholangiocytes that make up the bile ducts; or it can produce hepatocytes that are responsible for the major functions of the liver. To better study this important liver cell, we have established LPSC lines from both the mouse and human to understand what makes them grow and how they decide between generating cholangiocytes and hepatocytes.

This work has produced a valuable resource in the form of LPSC lines that are non-cancerous and others that are tumorigenic. This provides a platform for screening and testing for anti-liver cancer drugs that are selectively effective against liver cancer cells.

 

Emeritus Professor George Yeoh

Emeritus Professor George Yeoh

Liver Disease and Carcinogenesis

Read more

LATEST NEWS

Biodesign program wins national award for excellence

A program that provides industry engagement opportunities and training in biomedical design thinking, while giving industry access to research talent has won a national award. iPREP Biodesign, administered by The University of Western Australia on behalf of nine universities across the country, has been recognised with the 2024 Australian Council…

Read More
image shows ovarian cancer cells from various patients in various colours to show tumour elements

“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood

Perth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in the journal Nature Communications A cross-town collaboration involving researchers from the Harry Perkins Institute of Medical Research, St John of…

Read More

A cure for peripheral arterial disease?

Excitement is palpable among Harry Perkins Institute researchers as they progress the approval stages of a drug that may have the damaging peripheral artery disease on the run. First published by Medical Forum, and reproduced here with permission. By Eric Martin, 1 April 2024. Every few decades a revolutionary discovery…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS